El-Gabry Ehab 4
4 · Akoya Biosciences, Inc. · Filed May 23, 2022
Insider Transaction Report
Form 4
El-Gabry Ehab
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-05-19+150,000→ 150,000 totalExercise: $9.47Exp: 2032-05-19→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]Subject to the reporting person's continuing service, the options shall vest as follows: twenty-five percent (25%) shall have vested on April 11, 2023 with the remainder vesting in 36 equal monthly installments beginning on April 11, 2023.